等待開盤 09-20 09:30:00 美东时间
+2.120
+4.81%
新京报讯(记者张兆慧)近日,加科思发布的2023中报及2023年报的补充公告提及,终止SHP2变构抑制剂JAB-3068的临床开发,该消息引发广泛关注。 作为一...
08-26 17:59
北京时间2024年08月21日02时50分,诺瓦瓦克斯医药(NVAX.us)股票出现波动,股价大幅下跌5.00%。截至发稿,该股报13.21美元/股,成交量3...
08-21 02:50
Revolution Medicines Inc : JP Morgan Cuts Target Price to $54 From $55
08-08 11:08
In a report released yesterday, Marc Frahm from TD Cowen maintained a Buy ratin...
08-08 10:35
Revolution Medicines : Files for Common Stock Offering of up to $500 Mln- SEC F...
08-08 05:54
Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.77) by 5.19 percent. This is a 11.96 percent increase over losses of $(0.92) per share
08-08 05:25
Revolution Medicines Inc - Sees Current Cash, Cash Equivalents and Marketable S...
08-08 04:36
Revolution Medicines : Increases Board Size to Ten Directors
08-08 04:33
Revolution Medicines Q2 Operating Income USD -156.643 Million
08-08 04:05
Revolution Medicines Inc : Leerink Partners Raises Target Price to $55 From $53
07-22 18:19